TeachableMedicalNews article 04242020
Teachable moment in classrooms:
- blood chapter – white blood cell types and their functions
- blood chapter – malfunctioning mechanisms in leukemia
- respiratory system chapter – alveoli as the sites of gas exchange
- respiratory system chapter – immune defense cells of alveoli
- lymphatic and immune system chapter – events of inflammation
How could the leukemia fighter drug Calquence help us defeat the SARS-CoV-2 coronavirus?
The news item: Recent articles reported that the anti-cancer drug will be evaluated as potential treatment of SARS-CoV-2 infected patients:
AstraZeneca to test impact of cancer drug Calquence on coronavirus patients
Calquence (acalabrutinib) belongs to a class of drugs called Bruton’s tyrosine kinase (BTK) inhibitors which can suppress autoimmune diseases. The drug, which is currently used to treat certain types of blood cancers, has already been approved for the treatment of adult patients with chronic lymphocytic leukaemia in the U.S.
The news item mentions cytokine storm in coronavirus infected patients, and that the drug is a BTK inhibitor.